About the Journal

Journal of Cancer Metastasis and Treatment (JCMT) is an international peer-reviewed, open access, online journal.

Aims and Scope

The journal concerns cancer metastasis and treatment, including the occurrence, development, progression, metastasis, and treatment of neoplastic diseases. Its coverage includes basic, translational and clinical studies related to cancer cell biology, genomics, precision medicine, medical oncology, radiation therapy and radiology, obstetrics and gynecology, pediatrics, surgery, hematology, neuro-oncology, etc. Articles in the following areas are especially welcome:

  • Basic research on cancer occurrence and progression, focusing on molecular biology, cell biology, and genetics;
  • Mechanisms of metastasis and its prevention and control;
  • Basic and clinical research on treatment of primary, metastatic tumors and the like;
  • Improved methods for medical, radiological, and/or surgical treatment of metastatic tumors (immunotherapy, chemotherapy, radiotherapy, biological therapy, operative treatment, interventional therapy, etc.);
  • Observational/epidemiological studies focusing on environmental and behavioral factors that reduce the risk of cancer progression and metastasis and gene/environment interactions;
  • Primary and secondary prevention studies.

JCMT publishes high-quality original articles, reviews, case reports, commentaries, letters to editor, etc.


The journal is owned by OAE Publishing Inc.

Open Access

All articles published by JCMT are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access. Articles had been published under Attribution-NonCommercial-ShareAlike 3.0 Unported till October 2017, whereas the Attribution 4.0 International (CC BY 4.0) was further adopted afterwards. The CC BY allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.
Authors retain the copyright of their works as well as the rights to make certain uses of the works.

Editorial Board

For more information about the editorial team, please refer to Editorial Board.

Peer Review

The journal adheres to rigorous peer review process and undergoes single-blind peer review. For more details, please refer to Editorial and Peer Review Process and Peer Review Guidelines.

Publication Ethics Statement

Journal of Cancer Metastasis and Treatment is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines.

The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of Journal of Cancer Metastasis and Treatment take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.

Editorial Policies

All manuscripts submitted to JCMT should adhere to OAE's Editorial Policies.

Journal Information and Statistics

  • Launch date: April 15, 2015 
  • Publication model: Open access 
  • ISSN 2454-2857 (Online), ISSN 2394-4722 (Print)
  • Digital archive: Portico  
  • Frequency: Continuously published 
  • DOI: 10.20517/2394-4722 


    All articles published in JCMT are included in:
  • CAS 
  • CNKI 
  • DRJI 
  • EBSCO 
  • Eurasian Scientific Journal Index 
  • Google Scholar 
  • JournalGuide 
  • JournalTOCs 
  • J-Gate 
  • ResearchBib 
  • Root Indexing 
  • Wanfang Data


Please see our Contact Us  page for details about different queries.